The Food and Drug Administration () is under fire for backing the use of puberty blockers for children, even when officials knew they presented life-threatening health risks.
Internal FDA emails show how officials knew the drugs, which delay the onset of puberty, raise the risks of users having seizures, , and committing suicide.
Even so, FDA team chief Shannon Sullivan wrote in a January 2022 email to colleagues that 'there is definitely a need for these to drugs to be approved for transition.'
Load More
Yorumlar
Kalan Karakter: